(Total Views: 532)
Posted On: 04/30/2021 12:49:48 AM
Post# of 153886
Re: nothingspecial #88589
Thank you for the reply. I will admit, I don't know "who" I would want as a replacement to NP. I am a finance person, not a biotech person.
But, I just see the results and am convinced we can do better. I guess we would need to leave it to the BOD to make that decision. (I'm no fan of the BOD either, so this is a challenge!)
But, if our drug works and we can't generate meaningful revenue during this current "opportunity" (cruel, I know), then our management has failed.
If our drug doesn't work, then so be it. We don't deserve revenue. (I think the drug works.)
IMO, those that say a new CEO will only look for a quick buck, a reverse split or a below market buy-out are off base. This just doesn't make sense. What I hear is that they don't want a CEO who is only hoping for the greatest home run in history. We already have one of those, and I don't see progress since early 2020. I want a CEO who can deliver revenue and a positive share price from HERE FORWARD.
I would love to make a few bucks now and continue my investment in a deep-pocketed partner with a lot of experience developing and marketing drugs. This would be better for me and also for the world that needs a Covid treatment for critical patients.
IMO, CYDY will have a higher stock price and save more lives under different management. Shareholder since January 2016. Currently hold 76,000 shares, which is about half my original position.
But, I just see the results and am convinced we can do better. I guess we would need to leave it to the BOD to make that decision. (I'm no fan of the BOD either, so this is a challenge!)
But, if our drug works and we can't generate meaningful revenue during this current "opportunity" (cruel, I know), then our management has failed.
If our drug doesn't work, then so be it. We don't deserve revenue. (I think the drug works.)
IMO, those that say a new CEO will only look for a quick buck, a reverse split or a below market buy-out are off base. This just doesn't make sense. What I hear is that they don't want a CEO who is only hoping for the greatest home run in history. We already have one of those, and I don't see progress since early 2020. I want a CEO who can deliver revenue and a positive share price from HERE FORWARD.
I would love to make a few bucks now and continue my investment in a deep-pocketed partner with a lot of experience developing and marketing drugs. This would be better for me and also for the world that needs a Covid treatment for critical patients.
IMO, CYDY will have a higher stock price and save more lives under different management. Shareholder since January 2016. Currently hold 76,000 shares, which is about half my original position.
(5)
(0)
